Accumulating evidence suggests anti-TNF therapy needs to be given trial priority in COVID-19 treatment.

Robinson, Philip C; Richards, Duncan; Tanner, Helen L; Feldmann, Marc

Robinson, Philip C; Richards, Duncan; Tanner, Helen L; Feldmann, Marc.

Robinson PC; Faculty of Medicine, University of Queensland, Brisbane, QLD, Australia.
Richards D; Metro North Hospital and Health Service, Brisbane, QLD, Australia.
Tanner HL; Kennedy Institute of Rheumatology, Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, Botnar Research Centre, University of Oxford, Oxford OX3 7LD, UK.
Feldmann M; Faculty of Medicine, University of Queensland, Brisbane, QLD, Australia.

Lancet Rheumatol ; 2(11): e653-e655, 2020 Nov.

Article in English | MEDLINE | ID: covidwho-748134

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Type of study: Randomized controlled trials Language: English Journal: Lancet Rheumatol Year: 2020 Document Type: Article Affiliation country: S2665-9913(20)30309-X

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google